Fulcrum Therapeutics Inc (FULC)
3.355
-0.10
(-2.89%)
USD |
NASDAQ |
Sep 20, 16:00
3.355
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Shares Outstanding: 62.40M for July 24, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
July 24, 2024 | 62.40M |
June 30, 2024 | 62.25M |
May 06, 2024 | 62.15M |
April 18, 2024 | 62.15M |
March 31, 2024 | 62.14M |
February 20, 2024 | 61.94M |
December 31, 2023 | 61.92M |
October 31, 2023 | 61.82M |
September 30, 2023 | 61.82M |
July 27, 2023 | 61.82M |
June 30, 2023 | 61.82M |
May 08, 2023 | 61.76M |
April 10, 2023 | 61.76M |
March 31, 2023 | 61.76M |
March 02, 2023 | 61.76M |
January 20, 2023 | 61.67M |
December 31, 2022 | 52.10M |
November 01, 2022 | 52.05M |
September 30, 2022 | 52.05M |
August 23, 2022 | 52.04M |
August 18, 2022 | 50.60M |
August 04, 2022 | 41.01M |
June 30, 2022 | 41.01M |
May 02, 2022 | 40.85M |
April 11, 2022 | 40.82M |
Date | Value |
---|---|
March 31, 2022 | 40.68M |
February 24, 2022 | 40.64M |
December 31, 2021 | 40.63M |
October 28, 2021 | 40.55M |
September 30, 2021 | 40.53M |
August 16, 2021 | 40.30M |
August 03, 2021 | 32.71M |
July 31, 2021 | 32.71M |
June 30, 2021 | 32.66M |
April 29, 2021 | 32.68M |
April 12, 2021 | 32.59M |
March 31, 2021 | 32.59M |
February 25, 2021 | 32.67M |
January 22, 2021 | 32.55M |
January 08, 2021 | 27.95M |
January 07, 2021 | 27.95M |
December 31, 2020 | 27.94M |
November 04, 2020 | 27.46M |
September 30, 2020 | 27.28M |
August 04, 2020 | 27.45M |
June 30, 2020 | 27.22M |
June 15, 2020 | 27.42M |
June 09, 2020 | 27.40M |
May 08, 2020 | 23.37M |
April 14, 2020 | 23.36M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
22.56M
Minimum
Sep 30 2019
62.40M
Maximum
Jul 24 2024
42.32M
Average
40.63M
Median
Dec 31 2021
Shares Outstanding Benchmarks
Bioventus Inc | 65.19M |
Arcturus Therapeutics Holdings Inc | 27.04M |
Entrada Therapeutics Inc | 37.20M |
Johnson & Johnson | 2.407B |
Insmed Inc | 171.85M |